ABX464 150mg: Clinical Trials

1 trial of ABX464 150mg, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow ABX464 150mg: new trials by email Literature Review of ABX464 150mg trials Research Report on ABX464 150mg

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Safety, Pharmacokinetics, and Pharmacodynamics Study of ABX464 in HIV-1 Seronegative and Seropositive Adults
ABX464 150mg, ABX464 50mg - HIV Infections, Health Volunteers
Phase 1 / Phase 2CompletedAbivax S.A.362017-03-272023-03-31

Conditions studied

HIV Infections (1)

Sponsors

Abivax S.A. (1)

Countries

Spain (1)

Results publications

PMID 34436569